We rely on prominent scientists and physicians to advise us on our KinAce platform and the clinical development of KRX-101.

Prof. Shmuel Ben-Sasson is the inventor of the KinAce platform and serves as our Chief Scientific Officer. Dr. Ben-Sasson is the incumbent of the Joseph I. Bluestone Chair in Experimental Medicine and Professor of Cell Biology in the Department of Experimental Medicine and Cancer Research at Hebrew University Hadassah Medical School in Jerusalem. He is the holder of multiple patents and the inventor of the TUNEL Assay, the most commonly cited assay for apoptosis in the medical literature. Dr. Ben-Sasson also maintains an appointment as a Visiting Professor in the Department of Surgical Research at Harvard Medical School.

The KinAce Scientific Advisory Board:
Name
Current Position
James Broach, Ph.D.
  • Professor of Molecular Biology at Princeton University
Moshe Oren, Ph.D.
  • Dean of Biology at Weizmann Institute of Science (Rehovot, Israel)
Susan S. Taylor, Ph.D.
  • Professor of Chemistry and Biochemistry at the University of California, San Diego and Investigator at the Howard Hughes Medical Institute
David Lawrence, Ph.D.
  • Professor of Biochemistry at the Albert Einstein College of Medicine

The KRX-101 Scientific Advisory Board:
Name
Current Position
Steven M. Haffner, M.D.
  • Professor of Internal Medicine in the Department of Medicine/Clinical Epidemiology at the University of Texas Health Science Center.
Job Harenberg, Ph.D.
  • Professor of Internal Medicine and Head of the Department of Haemostaseology at the University Hospital Mannheim, Faculty of Medicine of the University of Heidelberg (Mannheim, Germany).
Michael Mauer, Ph.D.
  • Professor of Pediatrics, Co-Director, Pediatric Nephrology, University of Minnesota.
  • Director, Pediatric Solid Organ Transplantation, Fairview-University Medical Center.
Giuseppe Remuzzi, M.D, FRCP
  • Director, 'Mario Negri' Institute for Pharmacological Research-Negri Bergamo Laboratories.
  • Head, Department of Immunology and Clinics of Organ Transplantation, Ospedali Riuniti di Bergamo/Mario Negri Institute - Bergamo, Italy.
Bernard Zinman, Ph.D.
  • Director, Leadership at the Sinai Center for Diabetes.
  • Professor of Medicine, University of Toronto.
  • Head, Division of Endocrinology, Mount Sinai Hospital and University Health Network.